Recommending Cannabis in Montana
Note: Initiative 182 goes into effect June 30, 2017. ASA will provide updated information before the new law goes into effect.
Medical professionals recommending medical cannabis must be physicians duly licensed to practice medicine in Montana under MCA Title 37, Chapter 3. Physicians must assume primary responsibility for providing management and routine care of the patient’s debilitating medical condition, complete a full assessment of the patient’s medical history and current condition, review all prescription and non-prescription medications and supplements used by the patient, and attest to ongoing care. Physicians are required to discuss potential harms and side effects of medical cannabis with their patient.
Qualifying conditions include: cancer, glaucoma, HIV/AIDS, or the treatment of these conditions, a chronic or debilitating disease or medical condition or its treatment that produces: cachexia (wasting syndrome), severe or chronic pain, severe nausea, seizures (including seizures caused by epilepsy), severe or persistent muscle spasms (including spasms caused by multiple sclerosis or Crohn's disease), painful peripheral neuropathy, hospice care, and any other medical condition or treatment for a medical condition adopted by the Department of Public Health and Human Services.
Forms can be downloaded here.